The Indian Pharmacopoeial Commission publishes Indian Pharmacopoeia (IP) on regular basis.The current edition of IP 2018 along with its two Addendum (2019 & 2021) contains 173 Monographs of Herbal Drugs/Processed Drugs (Extracts, Essential oils, Etc)/Herbal Formulations. There is a need to integrate IPC with Industry partners, particularly the Herbal drug industries, which are engaged in the herbal drug quality control and phytopharmaceutical development. In order to further strengthen the standard setting process and to ensure the compliance of strong regulatory framework for Herbal Drugs and Phytopharmaceuticals (As per the recent amendment in Drugs & Cosmetics Act, 1940 and Rules, 1945 framed there under, the G.S.R. 227(E), there is a need to create awareness and train the Stakeholders (Academia, Industry, Regulators.
National Webinar On
Analytical Tools & Techniques for Phytopharmaceutical Monograph Development
30th November 2021
10:30 AM-4:45 PM
CSIR - National Botanical Research Institute
• The CSIR-National Botanical Research Institute (NBRI) - is amongst one of the constituent research institutes of the Council of Scientific and Industrial Research (CSIR), New Delhi.
Objectives
• Basic and applied research on plant diversity and prospection, plant-environment interaction and biotechnological approaches for plant improvement
• Dissemination of scientific knowledge and technologies on plants and microbial resources through publications, training, capacity building and extension activities.
Joint Efforts of IPC and CSIR-NBRI
Working together for phytopharmaceutical standards and to support in the compliance of phytopharmaceutical regulations.
OBJECTIVE OF THE PROGRAMME
• To create the awareness about the recent advancement in the field of quality standards and analytical techniques for herbal drugs and Phytopharmaceuticals.
• To address and redressal of the challenges associated within the development of standard setting procedures among the herbal drug and phytopharmaceutical drug products.
EXPECTED OUTCOME
• Phytopharmaceutical domain knowledge will expand among the profile users.
• Standard setting procedures related with the phytopharmaceutical drugs, will strengthen as the associated challenges may become redressed.
• Challenges associated with phytopharmaceutical drugs development may overcome through the execution of expansion of PPI monographs.
WHO SHOULD ATTEND?
• Industry personnel who are engaged in Herbal and phytopharmaceutical drug product research & development.
• Stakeholders/Researchers/Academicians which are actively involved in the development of quality standards for herbal and phytopharmaceutical drug
Registration Deadline : 28th November 2021
Maximum 100 participants will be allowed to attend the webinar on first come first serve basis.
FIND MORE CONFERENCES AT PHARMATUTOR
.png)
